A carregar...
COVID-19 and multiple sclerosis: A description of two cases on alemtuzumab
BACKGROUND: Alemtuzumab is a treatment for highly active multiple sclerosis (MS). Immunosuppression is considered a risk factor for SARS-CoV-2 infection and there is still lack of evidence to guide MS practice. METHODS/RESULTS: We describe the clinical and immunological evolution of two MS patients...
Na minha lista:
| Publicado no: | Mult Scler Relat Disord |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier B.V.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7366111/ https://ncbi.nlm.nih.gov/pubmed/32711297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2020.102402 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|